
Nway Biotech Private Limited
About Nway Biotech Private Limited
Data last updated:
Nway Biotech Private Limited is a private limited company based in Aurangabad, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 March 2022.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U21000MH2022PTC378142. Its GSTIN is 27AAICN1233F1ZQ (Maharashtra).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹50 Lakh. It is led by directors Tarun Nandkishor Sohinda and Viresh Rajesh Dasare.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Aurangabad, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.04 Cr, a growth of 141% compared to the previous year. For the same year it recorded a net profit of ₹20.74 Lakh (net margin 6.8%) and EBITDA of ₹44.55 Lakh (EBITDA margin 14.6%).
As per MCA filings, the company has open charges of ₹5.54 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Nway Biotech has one previous CIN (Corporate Identification Number): U24299MH2022PTC378142. The current CIN is U21000MH2022PTC378142, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U21000MH2022PTC378142 | Current |
| U24299MH2022PTC378142 | Previous |
Contact details
Nway Biotech Private Limited's registered office is in Aurangabad, Maharashtra.
- Registered AddressShop No 427 428 Cts No. 1554/B/2 Kalda Corner, Matrix Complex, Aurangabad, Maharashtra, India – 431001
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Nway Biotech is manufacturing. In detail, this covers manufacture of chemicals and chemical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 20 | Manufacture of chemicals and chemical products |
To see the full business activity and turnover split of Nway Biotech Private Limited, buy the company report.
Financials of Nway Biotech Private Limited
FY 2025 filings availableNway Biotech Private Limited reported revenue of ₹3.04 Cr (up 141% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 141% in the latest year. EBITDA rose 171% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹44.55 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹20.74 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 14.6% | |||
| Net Profit Margin | 6.8% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Nway Biotech Private Limited, buy the company report.
Board of directors of Nway Biotech Private Limited
Nway Biotech has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Viresh Rajesh Dasare Also directs: Surya Chemopharma LLP | Additional Director | 30 Aug 2022 | 4 Years 2 Months | Current |
| Tarun Nandkishor Sohinda | Director | 09 Mar 2022 | 4 Years 7 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 11 Dec 2024 | 101020380 | Others | ₹3.5 Cr | Open | |
| 28 Nov 2022 | 100646396 | Others | ₹2.04 Cr | Open |
To see the full charge records of Nway Biotech Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Nway Biotech Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nway Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Nway Biotech has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAICN1233F1ZQ | Maharashtra | Active | 11 Apr 2022 |
To see the full GST registrations and return filing status of Nway Biotech Private Limited, buy the company report.
Recent activity
Nway Biotech Private Limited has 3 board changes on record since 2022: 2 appointments and 1 cessation. The latest: Nandkishor Chandraprakash Soohinda ceased to be Director on 30 Aug 2022.
Frequently asked questions
Nway Biotech is an active private limited company based in Aurangabad, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 March 2022 (4+ years old) and is registered under CIN U21000MH2022PTC378142.
Nway Biotech has 2 current directors:
- Viresh Rajesh Dasare - Additional Director
- Tarun Nandkishor Sohinda - Director
The latest financial statements of Nway Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Nway Biotech is 27AAICN1233F1ZQ, registered in Maharashtra.
The CIN (Corporate Identification Number) of Nway Biotech is U21000MH2022PTC378142. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nway Biotech was incorporated on 09 March 2022, making it 4+ years old. It is registered with the Registrar of Companies, Mumbai.
Nandkishor Chandraprakash Soohinda ceased to be Director on 30 Aug 2022. Viresh Rajesh Dasare was appointed as Additional Director on 30 Aug 2022. Tarun Nandkishor Sohinda was appointed as Director on 09 Mar 2022.
The registered office of Nway Biotech is at Shop No 427 428 Cts No. 1554B2 Kalda Corner, Matrix Complex, Aurangabad, Maharashtra, India – 431001.
Nway Biotech operates in the pharma industry, in the drug formulation and development segment.
Nway Biotech has open charges of ₹5.54 Cr and no satisfied charges on record as per latest MCA filings.

